Drug Abuse Warning Network US (DAWN-NS-1997)

<p>The Drug Abuse Warning Network (DAWN) survey is designed to<br />
capture data on emergency department (ED) episodes that are induced by<br />
or related to the use of an illicit, prescription, or over-the-counter<br />
drug. For purposes of this collection, a drug "episode" is an ED visit<br />
that was induced by or related to the use of an illegal drug or the<br />
nonmedical use of a legal drug for patients aged six years and<br />
older. A drug "mention" refers to a substance that was mentioned<br />
during a drug-related ED episode. Because up to four drugs can be<br />
reported for each drug abuse episode, there are more mentions than<br />
episodes in the data. Individual persons may also be included more<br />
than once in the data. Within each facility participating in DAWN, a<br />
designated reporter, usually a member of the emergency department or<br />
medical records staff, was responsible for identifying drug-related<br />
episodes and recording and submitting data on each case. An episode<br />
report was submitted for each patient visiting a DAWN emergency<br />
department whose presenting problem(s) was/were related to their own<br />
drug use. DAWN produces estimates of drug-related emergency department<br />
visits for 50 specific drugs, drug categories, or combinations of<br />
drugs, including the following: acetaminophen, alcohol in combination<br />
with other drugs, alprazolam, amitriptyline, amphetamines, aspirin,<br />
cocaine, codeine, diazepam, diphenhydramine, fluoxetine,<br />
heroin/morphine, inhalants/solvents/aerosols, LSD, lorazepam,<br />
marijuana/hashish, methadone, methamphetamine, and PCP/PCP in<br />
combination with other drugs. The use of alcohol alone is not<br />
reported. The route of administration and form of drug used (e.g.,<br />
powder, tablet, liquid) are included for each drug. Data collected for<br />
DAWN also include drug use motive and total drug mentions in the<br />
episode, as well as race, age, patient disposition, reason for ED<br />
visit, and day of the week, quarter, and year of episode.This study has 1 Data Set.</p>

《药物滥用警报网络（DAWN）调查》旨在搜集急诊科（ED）因滥用、处方或非处方药物使用而引发的急诊病例数据。在本收集目的中，药物“病例”指因非法药物使用或合法药物非医疗用途（针对六岁及以上患者）而引发的急诊就诊。药物“提及”指在药物相关急诊病例中提到的物质。由于每个药物滥用病例可能报告多达四种药物，因此在数据中提及的数量多于病例数量。个体人员的数据也可能被重复记录。在参与DAWN的每个机构中，指定报告人，通常为急诊科或病历记录工作人员，负责识别药物相关病例并记录和提交每个病例的数据。对于每个因自身药物使用相关问题就诊于DAWN急诊科的患者，均需提交病例报告。DAWN对50种特定药物、药物类别或药物组合的药物相关急诊就诊进行了估计，包括以下内容：对乙酰氨基酚、与其他药物合用的酒精、阿普唑仑、阿米替林、安非他命、阿司匹林、可卡因、可待因、地西泮、苯海拉明、氟西汀、海洛因/吗啡、吸入剂/溶剂/气雾剂、LSD、劳拉西泮、大麻/大麻树脂、美沙酮、甲基苯丙胺和PCP/与其他药物合用的PCP。单独使用酒精的情况未进行报告。每种药物均记录了给药途径和药物形式（例如，粉末、片剂、液体）。收集的DAWN数据还包括药物使用动机、病例中提及的药物总数，以及种族、年龄、患者处置、急诊就诊原因以及病例发生的星期、季度和年份。本研究包含1个数据集。